These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2233906)

  • 41. Priming and induction of Haemophilus influenzae type b capsular antibodies in early infancy by Dpo20, an oligosaccharide-protein conjugate vaccine.
    Anderson P; Pichichero M; Edwards K; Porch CR; Insel R
    J Pediatr; 1987 Nov; 111(5):644-50. PubMed ID: 3499499
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of active and combined passive/active immunization of Navajo children against Haemophilus influenzae type b.
    Letson GW; Santosham M; Reid R; Priehs C; Burns B; Jahnke A; Gahagan S; Nienstadt L; Johnson C; Smith D
    Pediatr Infect Dis J; 1988 Nov; 7(11):747-52. PubMed ID: 3266005
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibody responses to four Haemophilus influenzae type b conjugate vaccines.
    Käyhty H; Eskola J; Peltola H; Rönnberg PR; Kela E; Karanko V; Saarinen L
    Am J Dis Child; 1991 Feb; 145(2):223-7. PubMed ID: 1994693
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluating the Haemophilus influenzae type b conjugate vaccine PRP-D.
    Robbins JB; Schneerson R
    N Engl J Med; 1990 Nov; 323(20):1415-6. PubMed ID: 2233910
    [No Abstract]   [Full Text] [Related]  

  • 45. Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccine.
    Clemens JD; Ferreccio C; Levine MM; Horwitz I; Rao MR; Edwards KM; Fritzell B
    JAMA; 1992 Feb; 267(5):673-8. PubMed ID: 1731134
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunogenicity of Haemophilus influenzae type b conjugate vaccines in infant rhesus monkeys.
    Vella PP; Ellis RW
    Pediatr Res; 1991 Jan; 29(1):10-3. PubMed ID: 2000253
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical experience with Haemophilus influenzae type b conjugate vaccines.
    Mäkelä PH; Eskola J; Peltola H; Takala AK; Käyhty H
    Pediatrics; 1990 Apr; 85(4 Pt 2):651-3. PubMed ID: 2179855
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines.
    Granoff DM; Rathore MH; Holmes SJ; Granoff PD; Lucas AH
    Vaccine; 1993; 11 Suppl 1():S46-51. PubMed ID: 8447176
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group.
    Schlesinger Y; Granoff DM
    JAMA; 1992 Mar; 267(11):1489-94. PubMed ID: 1538539
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Response to a Haemophilus influenzae type b diphtheria CRM197 conjugate vaccine in children with a defect of antibody production to Haemophilus influenzae type b polysaccharide.
    Schneider LC; Insel RA; Howie G; Madore DV; Geha RS
    J Allergy Clin Immunol; 1990 May; 85(5):948-53. PubMed ID: 2332568
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster.
    Booy R; Heath PT; Slack MP; Begg N; Moxon ER
    Lancet; 1997 Apr; 349(9060):1197-202. PubMed ID: 9130940
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in children with sickle hemoglobinopathy or malignancies, and after systemic Haemophilus influenzae type b infection.
    Kaplan SL; Duckett T; Mahoney DH; Kennedy LL; Dukes CM; Schaffer DM; Mason EO
    J Pediatr; 1992 Mar; 120(3):367-70. PubMed ID: 1538281
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Persistence of antibody and response to booster dose of Haemophilus influenzae type b polysaccharide diphtheria toxoid conjugate vaccine in infants immunized at 9 to 15 months of age.
    Lepow M; Randolph M; Cimma R; Larsen D; Rogan M; Schumacher J; Lent B; Gaintner S; Samuelson J; Gordon L
    J Pediatr; 1986 Jun; 108(6):882-6. PubMed ID: 3519914
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prospective comparison of the immune response of infants to three Haemophilus influenzae type b vaccines.
    Turner RB; Cimino CO; Sullivan BJ
    Pediatr Infect Dis J; 1991 Feb; 10(2):108-12. PubMed ID: 2062600
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunogenicity of Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine in patients who acquired Haemophilus disease despite previous vaccination with type b polysaccharide vaccine.
    Granoff DM; Chacko A; Lottenbach KR; Sheetz KE
    J Pediatr; 1989 Jun; 114(6):925-33. PubMed ID: 2786062
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Haemophilus influenzae type b conjugate vaccines: a review of efficacy data.
    Heath PT
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S117-22. PubMed ID: 9781743
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in children with sickle cell disease.
    Rubin LG; Voulalas D; Carmody L
    Am J Dis Child; 1992 Mar; 146(3):340-2. PubMed ID: 1543182
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids-pertussis vaccine at two, four and six months of age.
    Ferreccio C; Clemens J; Avendano A; Horwitz I; Flores C; Avila L; Cayazzo M; Fritzell B; Cadoz M; Levine M
    Pediatr Infect Dis J; 1991 Oct; 10(10):764-71. PubMed ID: 1945579
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical trials of the Haemophilus influenzae type b capsular polysaccharide-diphtheria toxoid conjugate vaccine.
    Lepow M
    Pediatr Infect Dis J; 1987 Aug; 6(8):804-7. PubMed ID: 3313246
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in US children aged 18-59 months. Haemophilus Influenzae Vaccine Efficacy Study Group.
    Wenger JD; Pierce R; Deaver KA; Plikaytis BD; Facklam RR; Broome CV
    Lancet; 1991 Aug; 338(8764):395-8. PubMed ID: 1678080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.